Evidence map›Paper›PMID 41198814›Full record

ArticleScientific reports2025

Cistromic insight into the association of retinoid X receptor with MyoD and CTCF in proliferating myoblasts.

Jean-Thomas Clément, Qiao Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jean-Thomas ClémentDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Room 2537,, Ottawa, K1H 8M5, ON, Canada.
Qiao LiDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Room 2537,, Ottawa, K1H 8M5, ON, Canada. qli@uottawa.ca.

Funding

Natural Sciences and Engineering Research Council of Canada 250174
6 · The paper itself

Abstract

In eukaryotic cells, histone acetylation and chromatin states affect gene expression programs in broad spectrum of cellular function. Comprehending the genomic signature of retinoid X receptor (RXR) will provide crucial insight into the molecular signaling pathways underlying stem cell fate transition. Here, we employ an integrative ChIP-seq approach to investigate the interplay of RXR with MyoD and CTCF in proliferating myoblasts. Our findings suggest an active enhancer distribution of RXR along with MyoD, marked by H3K18 and H3K27 acetylation, potentially mediated by histone acetyltransferase p300. On the other hand, RXR together with CTCF were mainly distributed to active promoters, marked by H3K9 acetylation. CTCF in proximity to RXR was also associated to nuclear receptor regulator NCOA1 and N-COR, suggesting a potential role in chromatin organization. Taken together, our analyses indicate a crucial interplay of MyoD and CTCF with RXR in the regulation of stem cell function.

Indexed as

CCCTC-Binding FactorMyoblastsMyoD ProteinRetinoid X ReceptorsAcetylationAnimalsCell LineCell ProliferationChromatinHistonesHumansMicePromoter Regions, GeneticProtein BindingCCCTC-Binding FactorChromatinHistonesMyoD1 myogenic differentiation proteinMyoD ProteinRetinoid X Receptors

Identifiers

PMID41198814
PMCPMC12592438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.